Correlation between quinolone susceptibility patterns and sequences in the A and B subunits of DNA gyrase in mycobacteria

被引:98
作者
Guillemin, I [1 ]
Jarlier, V [1 ]
Cambau, E [1 ]
机构
[1] Univ Pierre & Marie Curie, Fac Med Pitie Salpetriere, Lab Rech Mol Antibiot, F-75634 Paris 13, France
关键词
D O I
10.1128/AAC.42.8.2084
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The in vitro activities of seven quinolones and the sequences of the quinolone resistance determining regions (QRDR) in the A and B subunits of DNA gyrase were determined for 14 mycobacterial species, On the basis of quinolone activity, quinolones were arranged from that with the greatest to that with the least activity as follows: sparfloxacin, levofloxacin, ciprofloxacin, ofloxacin, pefloxacin, flumequine, and nalidixic acid. Based on MICs, the species could be organized into three groups: resistant (Mycobacterium avium, M. intracellulare, M. marinum, M. chelonae, M. abscessus [ofloxacin MICs, greater than or equal to 8 mu g/ml]), moderately susceptible (M. tuberculosis, M. bovis BCG, M. kansasii, M. leprae, M. fortuitum third biovariant, M. smegmatis [ofloxacin MICs, 0.5 to 1 mu g/ml]), and susceptible (M. fortuitum, M. peregrinum, M. aurum [ofloxacin MICs, less than or equal to 0.25 mu g/ml]). Peptide sequences of the QRDR of GyrB were identical in all the species, including the amino acids at the three positions known to be involved in acquired resistance to quinolone, i.e,, 426 (Asp), 447 (Arg), and 464 (Asn) (numbering system used for Escherichia coli), The last two residues could be involved in the overall low level of susceptibility of mycobacteria to quinolones since they differ from those found in the very susceptible E. coli (Lys-447 and Ser-464) but are identical to those found in the less susceptible Staphylococcus aureus and Streptococcus pneumoniae. Peptide sequences of the QRDR of GyrA were identical in all the species, except for the amino acid at position 83, which was an alanine in the two less susceptible groups and a serine in the most susceptible one, as in E. coli, suggesting that this amino acid is involved in the observed differences of quinolone susceptibility within the Mycobacterium genus.
引用
收藏
页码:2084 / 2088
页数:5
相关论文
共 35 条
[1]   The clinical use of fluoroquinolones for the treatment of mycobacterial diseases [J].
Alangaden, GJ ;
Lerner, SA .
CLINICAL INFECTIOUS DISEASES, 1997, 25 (05) :1213-1221
[2]   NEISSERIA-GONORRHOEAE ACQUIRES MUTATIONS IN ANALOGOUS REGIONS OF GYRA AND PARC IN FLUOROQUINOLONE-RESISTANT ISOLATES [J].
BELLAND, RJ ;
MORRISON, SG ;
ISON, C ;
HUANG, WM .
MOLECULAR MICROBIOLOGY, 1994, 14 (02) :371-380
[3]   Structure and mechanism of DNA topoisomerase II [J].
Berger, JM ;
Gamblin, SJ ;
Harrison, SC ;
Wang, JC .
NATURE, 1996, 379 (6562) :225-232
[4]   Crystal structure of the breakage-reunion domain of DNA gyrase [J].
Cabral, JHM ;
Jackson, AP ;
Smith, CV ;
Shikotra, N ;
Maxwell, A ;
Liddington, RC .
NATURE, 1997, 388 (6645) :903-906
[5]   Resistance to quinolones in mycobacteria [J].
Cambau, E ;
Jarlier, V .
RESEARCH IN MICROBIOLOGY, 1996, 147 (1-2) :52-59
[6]  
CHEN X, 1996, J INFECT DIS, V174, P1127
[7]   STRUCTURE-ACTIVITY-RELATIONSHIPS OF THE FLUOROQUINOLONES [J].
CHU, DTW ;
FERNANDES, PB .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (02) :131-135
[8]   Uncommon occurrence of mutations in the gyrB gene associated with quinolone resistance in clinical isolates of Neisseria gonorrhoeae [J].
Deguchi, T ;
Yasuda, M ;
Nakano, M ;
Ozeki, S ;
Kanematsu, E ;
Kawada, Y ;
Ezaki, T ;
Saito, I .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (10) :2437-2438
[9]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+
[10]  
GENSBERG K, 1995, FEMS MICROBIOL LETT, V132, P57, DOI 10.1016/0378-1097(95)00287-F